The AmoyDx® HANDLE Melanoma NGS Panel is an advanced next-generation sequencing (NGS) assay designed to qualitatively detect single nucleotide variants (SNVs), insertions and deletions (InDels) within pivotal melanoma tumor genes, utilizing DNA extracted from FFPE tumor tissue specimens.